LifeScience
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...
January 09, 2024 | News
Beckman Coulter Launches Groundbreaking Anti-TRBC2 Conjugated Antibody for Flow Cytometry
Traditional approaches to identify clonal T-cell expansion have been complex and challenging, relying on the assessment of abnormal antigen expression, whi...
January 09, 2024 | News
GenScript, GenScript ProBio, and Legend Biotech to Showcase Innovations at 42nd JPM Healthcare Conference
This initiative aims to showcase GenScript's exceptional strength and development potential in the biotech sector, seeking to establish deeper interactions...
January 05, 2024 | News
Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna
First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...
January 05, 2024 | News
Thermo Fisher Introduces PangenomiX Array for Large-Scale Disease and Pharmacogenomics Research
Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more ...
January 05, 2024 | News
Allorion Therapeutics and AstraZeneca Ink Exclusive Deal for EGFR L858R Inhibitor Program
Under the terms of the agreement, AstraZeneca will be granted an exclusive option to license a novel EGFR L858R allosteric inhibitor to develop and co...
January 03, 2024 | News
Agilent Technologies Consolidates Cell Analysis Division into Diagnostics and Genomics Group for Strategic Growth
Agilent Technologies Inc. (NYSE: A) announced it has moved the company's Cell Analysis Division into its Diagnostics and Genomics Group (DGG) a...
January 02, 2024 | News
HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions
Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...
December 29, 2023 | News
Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...
December 29, 2023 | News
2024 GenScript Biotech Global Forum to Propel Cell and Gene Therapy Innovations
The innovative development of biopharmaceuticals has ushered in a new era for disease treatment, bringing unprecedented hope to countless patients. However...
December 26, 2023 | News
Everest Medicines' Partner Calliditas Announces Nefecon® as Sole FDA-Approved Treatment for Slowing IgA Nephropathy Kidney Decline
The FDA approval is for adults with primary IgAN who are at risk for disease progression, irrespective of proteinuria levels. Nefecon® is now a...
December 21, 2023 | News
Dx&Vx Partners with LG CNS to Develop Bio-Health Data Platform in South Korea
Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI ...
December 21, 2023 | News
Roche's Navify Digital Solutions Earn High Ratings in KLAS Research
Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilita...
December 20, 2023 | News
ArisGlobal Introduces LifeSphere® NavaX™ - The Next-Generation Cognitive Computing Engine
NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies ArisGlobal, a market leader in Life Scien...
December 15, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
